Clover Health Investments (CLOV) Tops Q2 EPS by 1c; raises guidance

Clover Health Investments (NASDAQ: CLOV) reported Q2 EPS of $0.05, $0.01 better than the analyst estimate of $0.04. Revenue for the quarter came in at $743.2 million versus the consensus estimate of $728.27 million.

GUIDANCE:

Clover Health Investments sees FY2026 revenue of $2.92-3 million, versus the consensus of $2.91 million.

For earnings history and earnings-related data on Clover Health Investments (CLOV) click here.

You May Also Be Interested In

• Vicor raises Q3 2026 revenue guidance on new licensing deal
• H2O America unit gets approval for Cibolo Valley wastewater deal
• DSS, Inc. receives $500,000 loan from related party Alset Inc.